• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Design and synthesis of 6-oxo-1,4,5,6-tetrahydropyrimidine-5-carboxylate derivatives as neuraminidase inhibitors

tetano

Editor, Senior Moderator
Eur J Med Chem. 2014 Jun 26;83C:466-473. doi: 10.1016/j.ejmech.2014.06.059. [Epub ahead of print]
Design and synthesis of 6-oxo-1,4,5,6-tetrahydropyrimidine-5-carboxylate derivatives as neuraminidase inhibitors.
Lou J1, Yang X1, Rao Z1, Qi W1, Li J1, Wang H1, Li Y1, Li J1, Wang Z1, Hu X1, Liu P2, Hong X1.
Author information
Abstract

A series of 6-oxo-1,4,5,6-tetrahydropyrimidine-5-carboxylate derivatives were prepared to evaluate their ability of inhibiting neuraminidase (NA) of influenza A virus. All the compounds were synthesized in good yields starting from aldehyde by using a suitable synthetic strategy, which showed moderate inhibitory activity against influenza A NA. Compound 6g exhibited the strongest inhibitory activity against influenza virus A NA (IC50 = 17.64 μM), which indicated pyrimidine ring could be used as a core structure to design novel influenza NA inhibitors.

Copyright ? 2014. Published by Elsevier Masson SAS.
KEYWORDS:

6-oxo-1,4,5,6-tetrahydropyrimidine-5-carboxylate derivatives; Anti-influenza; Neuraminidase inhibitors; SAR

PMID:
24992074
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24992074
 
Back
Top Bottom